{"entity":{"type":"insider","cik":"0001551246","url":"/insider/0001551246","json_url":"/insider/0001551246.json","name":"Sinclair Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":9,"first":"2015-11-06","last":"2022-06-15","span_basis":"filed_date"},"name_variants":[{"name":"Sinclair Michael","source":"filing","n_filings":9,"first_seen":"2015-11-06","last_seen":"2022-06-15"}],"transactions":[{"id":6286066,"accession":"0001385508-22-000092","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-22-000092","line_url":"/filing/0001385508-22-000092#line-3","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":10.6,"price_display":"10.60","price_state":"stated","total_value":9540.0,"total_display":"9,540.00","total_whole":"9,540","shares_owned_after":19220.0,"shares_owned_after_display":"19,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-15","filed_date":"2022-06-15","scope":"insider"},{"id":6286062,"accession":"0001385508-22-000092","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-22-000092","line_url":"/filing/0001385508-22-000092#line-2","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7225.0,"shares_display":"7,225","price_per_share":10.9,"price_display":"10.90","price_state":"stated","total_value":78752.5,"total_display":"78,752.50","total_whole":"78,753","shares_owned_after":20120.0,"shares_owned_after_display":"20,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-14","filed_date":"2022-06-15","scope":"insider"},{"id":6286058,"accession":"0001385508-22-000092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000092","line_url":"/filing/0001385508-22-000092#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5491.0,"shares_display":"5,491","price_per_share":11.09,"price_display":"11.09","price_state":"stated","total_value":60895.19,"total_display":"60,895.19","total_whole":"60,895","shares_owned_after":27345.0,"shares_owned_after_display":"27,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-13","filed_date":"2022-06-15","scope":"insider"},{"id":6438113,"accession":"0001385508-22-000074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000074","line_url":"/filing/0001385508-22-000074#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7896.0,"shares_display":"7,896","price_per_share":12.25,"price_display":"12.25","price_state":"stated","total_value":96726.0,"total_display":"96,726.00","total_whole":"96,726","shares_owned_after":32836.0,"shares_owned_after_display":"32,836","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-09","filed_date":"2022-06-13","scope":"insider"},{"id":6617626,"accession":"0001385508-22-000072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-22-000072","line_url":"/filing/0001385508-22-000072#line-2","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":12.86,"price_display":"12.86","price_state":"stated","total_value":10288.0,"total_display":"10,288.00","total_whole":"10,288","shares_owned_after":40732.0,"shares_owned_after_display":"40,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-07","filed_date":"2022-06-08","scope":"insider"},{"id":6617624,"accession":"0001385508-22-000072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000072","line_url":"/filing/0001385508-22-000072#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7688.0,"shares_display":"7,688","price_per_share":12.94,"price_display":"12.94","price_state":"stated","total_value":99482.72,"total_display":"99,482.72","total_whole":"99,483","shares_owned_after":41532.0,"shares_owned_after_display":"41,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-08","scope":"insider"},{"id":6557262,"accession":"0001385508-22-000068","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-22-000068","line_url":"/filing/0001385508-22-000068#line-2","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10264.0,"shares_display":"10,264","price_per_share":13.59,"price_display":"13.59","price_state":"stated","total_value":139487.76,"total_display":"139,487.76","total_whole":"139,488","shares_owned_after":49220.0,"shares_owned_after_display":"49,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-06","scope":"insider"},{"id":6557258,"accession":"0001385508-22-000068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000068","line_url":"/filing/0001385508-22-000068#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9736.0,"shares_display":"9,736","price_per_share":13.88,"price_display":"13.88","price_state":"stated","total_value":135135.68,"total_display":"135,135.68","total_whole":"135,136","shares_owned_after":59484.0,"shares_owned_after_display":"59,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-06","scope":"insider"},{"id":4692483,"accession":"0001385508-21-000119","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001385508-21-000119","line_url":"/filing/0001385508-21-000119#line-6","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50269.0,"shares_display":"50,269","price_per_share":14.69,"price_display":"14.69","price_state":"stated","total_value":738451.61,"total_display":"738,451.61","total_whole":"738,452","shares_owned_after":144070.0,"shares_owned_after_display":"144,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-25","filed_date":"2021-08-25","scope":"insider"},{"id":4692476,"accession":"0001385508-21-000119","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001385508-21-000119","line_url":"/filing/0001385508-21-000119#line-4","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34607.0,"shares_display":"34,607","price_per_share":15.71,"price_display":"15.71","price_state":"stated","total_value":543675.97,"total_display":"543,675.97","total_whole":"543,676","shares_owned_after":144070.0,"shares_owned_after_display":"144,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-24","filed_date":"2021-08-25","scope":"insider"},{"id":4692467,"accession":"0001385508-21-000119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-21-000119","line_url":"/filing/0001385508-21-000119#line-2","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65124.0,"shares_display":"65,124","price_per_share":16.5,"price_display":"16.50","price_state":"stated","total_value":1074546.0,"total_display":"1,074,546.00","total_whole":"1,074,546","shares_owned_after":144070.0,"shares_owned_after_display":"144,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-25","scope":"insider"},{"id":8039412,"accession":"0001385508-19-000092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-19-000092","line_url":"/filing/0001385508-19-000092#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":12.52,"price_display":"12.52","price_state":"stated","total_value":751200.0,"total_display":"751,200.00","total_whole":"751,200","shares_owned_after":69220.0,"shares_owned_after_display":"69,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-12","filed_date":"2019-09-13","scope":"insider"},{"id":5142106,"accession":"0001144204-17-002536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-002536","line_url":"/filing/0001144204-17-002536#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":7.005,"price_display":"7.00","price_state":"stated","total_value":24517.5,"total_display":"24,517.50","total_whole":"24,518","shares_owned_after":132720.0,"shares_owned_after_display":"132,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-17","filed_date":"2017-01-17","scope":"insider"},{"id":9236775,"accession":"0001144204-15-069192","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-069192","line_url":"/filing/0001144204-15-069192#line-1","is_derivative":false,"issuer_cik":"0001551246","issuer_name":"Lightlake Therapeutics Inc.","issuer_ticker":"LLTP","issuer_name_source":null,"issuer_url":"/issuer/0001551246","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1700.0,"shares_display":"1,700","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":5950.0,"total_display":"5,950.00","total_whole":"5,950","shares_owned_after":144070.0,"shares_owned_after_display":"144,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-15","filed_date":"2015-12-03","scope":"insider"},{"id":8365204,"accession":"0001144204-15-063192","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-15-063192","line_url":"/filing/0001144204-15-063192#line-3","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"Lightlake Therapeutics Inc.","issuer_ticker":"LLTP","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001551246","owner_name":"Sinclair Michael","owner_display_name":"Sinclair Michael","owner_url":"/insider/0001551246","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1700.0,"shares_display":"1,700","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":5950.0,"total_display":"5,950.00","total_whole":"5,950","shares_owned_after":75585.0,"shares_owned_after_display":"75,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-15","filed_date":"2015-11-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001385508","name":"OPIANT PHARMACEUTICALS, INC.","url":"/issuer/0001385508","role":"Director, Officer (Executive Chairman), Ten percent owner","n_filings":9,"first_seen":"2015-11-06","last_seen":"2022-06-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001551246","retrieved_at":"2026-08-27T03:19:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}